Modeling Nonalcoholic Fatty Liver Disease in the Dish Using Human-Specific Platforms: Strategies and Limitations

被引：11
|
作者：
Rezvani, Milad [1 ,2 ,3 ,4 ]
Vallier, Ludovic [3 ,5 ]
Guillot, Adrien [6 ,7 ,8 ,9 ]
机构：
[1] Charite Univ Med Berlin, Dept Pediat Gastroenterol Nephrol & Metab Med, Berlin, Germany
[2] Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH USA
[3] Berlin Inst Hlth, Ctr Regenerat Therapies BCRT, Berlin, Germany
[4] Berlin Inst Hlth, Clinician Sci Program, Berlin, Germany
[5] Max Planck Inst Mol Genet, Berlin, Germany
[6] Charite Univ Med Berlin, Campus Virchow Klinikum, Berlin, Germany
[7] Campus Charite Mitte, Dept Hepatol & Gastroenterol, Berlin, Germany
[8] Charite Univ Med Berlin, Campus Virchow Klinikum, D-13353 Berlin, Germany
[9] Campus Charite Mitte, Dept Hepatol & Gastroenterol, D-13353 Berlin, Germany
来源：
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY | 2023年 / 15卷 / 05期
关键词：
Induced Pluripotent Stem Cells; Liver-on-Chip; Precision-Cut Liver Slices; Liver Organoids; PLURIPOTENT STEM-CELLS; PRECISION-CUT LIVER; CHOLANGIOCYTE ORGANOIDS; GENE-EXPRESSION; HEPATOCYTES; GENERATION; METABOLISM; EPITHELIUM; SLICES; MOUSE;
D O I：
10.1016/j.jcmgh.2023.01.014
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
This review article presents the latest research on nonal-coholic fatty liver disease (NAFLD) in vitro modeling. Ben-efits and limitations of using human induced pluripotent stem cell-derived approaches, primary organoids, liver-on-a-chip, and precision-cut liver sections are discussed to help researchers choose the most appropriate model.
引用
收藏
页码：1135 / 1145
页数：11
相关论文
共 50 条
  • [41] Pathways underlying iron accumulation in human nonalcoholic fatty liver disease
    Aigner, Elmar
    Theurl, Igor
    Theurl, Milan
    Lederer, Dieter
    Haufe, Heike
    Dietze, Otto
    Strasser, Michael
    Datz, Christian
    Weiss, Guenter
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2008, 87 (05): : 1374 - 1383
  • [42] Novel hepatic microRNAs upregulated in human nonalcoholic fatty liver disease
    Soronen, Jarkko
    Yki-Jarvinen, Hannele
    Zhou, You
    Sadevirta, Sanja
    Sarin, Antti-Pekka
    Leivonen, Marja
    Sevastianova, Ksenia
    Perttila, Julia
    Laurila, Pirkka-Pekka
    Sigruener, Alexander
    Schmitz, Gerd
    Olkkonen, Vesa M.
    PHYSIOLOGICAL REPORTS, 2016, 4 (01):
  • [43] Glucose and Mitochondrial Metabolism in Human Subjects with Nonalcoholic Fatty Liver Disease
    Sunny, Nishanth E.
    Parks, Elizabeth J.
    Browning, Jeffrey D.
    Burgess, Shawn C.
    DIABETES, 2011, 60 : A25 - A26
  • [44] Natural Compounds for Counteracting Nonalcoholic Fatty Liver Disease (NAFLD): Advantages and Limitations of the Suggested Candidates
    Salvoza, Noel
    Giraudi, Pablo J.
    Tiribelli, Claudio
    Rosso, Natalia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (05)
  • [45] PBPK modeling of impact of nonalcoholic fatty liver disease on toxicokinetics of perchloroethylene in mice
    Dalaijamts, Chimeddulam
    Cichocki, Joseph A.
    Luo, Yu-Syuan
    Rusyn, Ivan
    Chiu, Weihsueh A.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2020, 400
  • [46] Mice Hepatic Organoids for Modeling Nonalcoholic Fatty Liver Disease and Drug Response
    Zhou, Zheng
    Zheng, Xiyan
    Xie, Maoyun
    Lin, Zhiqun
    Du, Fei
    Shi, Xianjie
    Li, Ruixi
    STEM CELLS AND DEVELOPMENT, 2024, 33 (15-16) : 387 - 398
  • [47] Human-specific dual regulations of FXR-activation for reduction of fatty liver using in vitro cell culture model
    Miyazaki, Teruo
    Honda, Akira
    Ikegami, Tadashi
    Iida, Takashi
    Matsuzaki, Yasushi
    JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 2019, 64 (02) : 112 - 123
  • [48] Nonalcoholic Fatty Liver Disease, Metabolic Dysfunction Associated Fatty Liver Disease, and Associations with All-Cause and Cause Specific Mortality
    Huang, Qi
    Zou, Xiantong
    Zhou, Xianghai
    Ji, Linong
    DIABETES, 2021, 70
  • [49] Noninvasive diagnosis of nonalcoholic fatty liver disease using serum biomarkers
    Mitry, Ragai R.
    De Bruyne, Ruth
    Quaglia, Alberto
    Hughes, Robin D.
    Dhawan, Anil
    HEPATOLOGY, 2007, 46 (06) : 2047 - 2048
  • [50] HISTOLOGICAL SCORING OF NONALCOHOLIC FATTY LIVER DISEASE USING DEEP LEARNING
    Overgaard, Agnete
    Eschen, Christian
    Oro, Denise
    Veidal, Sanne
    HEPATOLOGY, 2019, 70 : 1059A - 1059A
12345